ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2024

Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial.

Robert T Naismith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.